Gilead Sciences Inc (NASDAQ: GILD)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 04/03/2020
Closing price: 78.21
|Support price level:||$72.27|
|Resistance price level:||N/A|
|Relative strength index (14-day RSI)||61.5|
- GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- GILD is one of this month's top performers with a return of -2.5 percent, beating 90 percent of stocks in the S&P-100.
- Up 7.4 percent, GILD is one of this week's biggest gainers.
- The price of this low-beta stock is expected to increase by 0.16% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 15.4% in the next week.
- 18.6% in the next month.
- 57.9% in the next year.